{
  "ptid_time": "014_S_4079_2011-06-16",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4079/2011-06-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 19,316 mm³, 13.5% below the reference mean. With a Z-score of -0.34 (36.8th percentile), this represents normal volume ; hippocampal volume measures 5,799 mm³, 24.5% below the reference mean. With a Z-score of -2.75 (0.3th percentile), this represents significant atrophy; whole brain volume measures 1,030,240 mm³, 0.1% above the reference mean. With a Z-score of 0.01 (50.5th percentile), this represents normal volume ; entorhinal cortex volume measures 2,698 mm³, 30.7% below the reference mean. With a Z-score of -2.38 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,239 mm³, 21.8% below the reference mean. With a Z-score of -2.46 (0.7th percentile), this represents significant atrophy; middle temporal gyrus volume measures 16,494 mm³, 19.6% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 64.5 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Hematopoietic-Lymphatic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 25.0. MoCA: 21.0. Logical Memory: 4.0. Laboratory findings: Serum Glucose: 153.00 (profound elevated); Total Protein: 6.20 (significant reduced); LDH: 249.00 (significant elevated); Triglycerides (GPO): 340.00 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated); Amyloid beta: 704.50 pg/mL (normal ); Total tau: 532.50 pg/mL (profound elevated); Phosphorylated tau: 50.27 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and moderate atrophy in the middle temporal gyrus—key regions affected in Alzheimer's disease (AD). Despite normal Aβ levels, the profound elevation in T-tau, P-tau, and AV45 (amyloid PET) suggests AD pathology. Cognitive scores (MMSE 25, MoCA 21) indicate mild impairment.  \n**Diagnosis:** **Dementia (likely Alzheimer’s disease, atypical amyloid-positive tauopathy variant)**  \n**Confidence:** **High** (due to biomarker and structural consistency with AD, despite normal Aβ).  \n\n*Note:* The discrepancy between normal Aβ and elevated tau/AV45 may suggest a rare tau-predominant AD subtype or mixed pathology, warranting further investigation.",
  "timestamp": "2025-07-25T23:51:03.067836"
}